Philip Renaud

Executive

CA·SEDI

Kane Biotech Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€177k

Latest filing published 21 Oct 2026 for Kane Biotech Inc..

Filing timeline

BuySale

Philip Renaud

Insider track record

Disclosed buys

Disclosed sells

Signal history

Philip Renaud: trading record in brief

Philip Renaud discloses dealings in Kane Biotech Inc. to SEDI. The record holds 25 filings, for trades running from 15 September 2010 to 16 October 2026.

No open-market purchase appears, only 1 sale worth €177k. Other entries cover 4 option exercises.

The latest filing, published on 21 October 2026, reports a transaction in Kane Biotech Inc. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Philip Renaud

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Kane Biotech Inc. (CA)

Declarations25 total

●
Philip Renaud
4 - Director of IssuerExecutives16 Oct 2026Kane Biotech Inc.
0SEDI
NotesTSXSEDI:4793395
●
Philip Renaud
4 - Director of IssuerExecutives26 Jun 2025Kane Biotech Inc.
0SEDI
@ €0.0627Convertible DebenturesTSXSEDI:4724819
●
Philip Renaud
4 - Director of IssuerExecutives15 Sept 2010Kane Biotech Inc.
0SEDI
Convertible DebenturesTSXSEDI:4724814
◇
Philip Renaud
4 - Director of IssuerExecutives25 May 2026Kane Biotech Inc.
1M CAD0SEDI
20,000,000 shares@ CA$0.0654.5% of flowWarrantsTSXSEDI:4724813
●
Philip Renaud
4 - Director of IssuerExecutives25 May 2026Kane Biotech Inc.
1M CAD16SEDI
20,000,000 shares@ CA$0.0545.5% of flowCommon SharesTSXSEDI:4724810
●
Philip Renaud
4 - Director of IssuerExecutives17 Dec 2025Kane Biotech Inc.
700,000 CAD13SEDI
14,000,000 shares@ CA$0.0521.5% of flowCommon SharesTSXSEDI:4624724
●
Philip Renaud
4 - Director of IssuerExecutives5 May 2025Kane Biotech Inc.
1M CAD13SEDI
10,000,000 shares@ CA$0.1018.9% of flowCommon SharesTSXSEDI:4506831
●
Philip Renaud
4 - Director of IssuerExecutives17 Jan 2025Kane Biotech Inc.
100,000 CAD11SEDI
1,000,000 shares@ CA$0.102.0% of flowCommon SharesTSXSEDI:4439070
▼
Philip Renaud
4 - Director of IssuerExecutives17 Apr 2024Kane Biotech Inc.
260,000 CAD11SEDI
2,000,000 shares@ CA$0.133.8% of flowCommon SharesTSXSEDI:4303491
◇
Philip Renaud
4 - Director of IssuerExecutives22 Apr 2021Kane Biotech Inc.
180,000 CAD11SEDI
1,000,000 shares@ CA$0.183.5% of flowCommon SharesTSXSEDI:3733579
●
Philip Renaud
4 - Director of IssuerExecutives19 Dec 2019Kane Biotech Inc.
300,000 CAD12SEDI
2,142,857 shares@ CA$0.1413.1% of flowCommon SharesTSXSEDI:3472206
●
Philip Renaud
4 - Director of IssuerExecutives8 Dec 2017Kane Biotech Inc.
12,000 CAD15SEDI
100,000 shares@ CA$0.120.2% of flowCommon SharesTSXSEDI:3095543
●
Philip Renaud
4 - Director of IssuerExecutives14 Jul 2017Kane Biotech Inc.
2M CAD15SEDI
12,500,000 shares@ CA$0.1223.0% of flowCommon SharesTSXSEDI:3038513
●
Philip Renaud
4 - Director of IssuerExecutives28 Mar 2017Kane Biotech Inc.
12,439 CAD11SEDI
80,251 shares@ CA$0.1550.4% of flowCommon SharesTSXSEDI:2985042
●
Philip Renaud
4 - Director of IssuerExecutives13 Mar 2017Kane Biotech Inc.
0SEDI
36,400,000 sharesCommon SharesTSXSEDI:2975412
●
Philip Renaud
4 - Director of IssuerExecutives13 Mar 2017Kane Biotech Inc.
0SEDI
9,866,412 sharesCommon SharesTSXSEDI:2975409
●
Philip Renaud
4 - Director of IssuerExecutives19 Dec 2016Kane Biotech Inc.
0SEDI
251,385 sharesCommon SharesTSXSEDI:2934341
●
Philip Renaud
4 - Director of IssuerExecutives28 Sept 2016Kane Biotech Inc.
12,830 CAD11SEDI
256,600 shares@ CA$0.050.3% of flowCommon SharesTSXSEDI:2894782
●
Philip Renaud
4 - Director of IssuerExecutives7 Jul 2016Kane Biotech Inc.
12,718 CAD11SEDI
254,369 shares@ CA$0.050.3% of flowCommon SharesTSXSEDI:2863219
◇
Philip Renaud
4 - Director of IssuerExecutives3 May 2016Kane Biotech Inc.
682,500 CAD12SEDI
22,750,000 shares@ CA$0.0313.8% of flowCommon SharesTSXSEDI:2832918
◇
Philip Renaud
4 - Director of IssuerExecutives3 May 2016Kane Biotech Inc.
169,744 CAD11SEDI
5,658,146 shares@ CA$0.033.4% of flowCommon SharesTSXSEDI:2832917
●
Philip Renaud
4 - Director of IssuerExecutives7 Apr 2016Kane Biotech Inc.
12,718 CAD11SEDI
254,369 shares@ CA$0.050.3% of flowCommon SharesTSXSEDI:2823574
●
Philip Renaud
4 - Director of IssuerExecutives7 Apr 2016Kane Biotech Inc.
0SEDI
22,750,000 sharesCommon SharesTSXSEDI:2822484
●
Philip Renaud
4 - Director of IssuerExecutives7 Apr 2016Kane Biotech Inc.
0SEDI
22,750,000 sharesCommon SharesTSXSEDI:2822488
●
Philip Renaud
4 - Director of IssuerExecutives15 Sept 2010Kane Biotech Inc.
0SEDI
Common SharesTSXSEDI:2822486

25 of 25 declarations

Philip Renaud

Insider track record

Philip Renaud: trading record in brief

Companies and markets linked to Philip Renaud

Related entities